Research compound supplied in Australia by Pulse Biolabs for laboratory use. Available in 5mg.
Could the part of growth hormone that acts on fat be separated from the parts that drive growth? AOD-9604 was Australia's attempt to find out, and its clinical programme is a lesson in how ideas get tested.
AOD-9604 is a synthetic 16-amino-acid fragment of human growth hormone, residues 177 to 191 with an added tyrosine, designed in Melbourne to keep the hormone's fat-related action without its growth effects. It is studied as an example of a mechanism that worked in rodents but did not carry through to people. Evidence comes from mouse and rat studies and from six human obesity trials, the largest of which found no weight-loss effect beyond diet and exercise.
Read the full research note →| Presentation | Code | Status | Price |
|---|---|---|---|
| 5mg | 5AD | In stock | $80 |
No batch-specific test report is currently published for this product. What a report does and does not show.
Supplied as lyophilised (freeze-dried) powder in a sealed vial. Store sealed and protected from light at the conditions stated on the product label or supplied specification. Solvent choice, concentration and handling after reconstitution depend on the compound and on the laboratory’s own procedures, and are not specified here.
AOD-9604 is not an approved medicine in Australia and has not been approved by any regulator; its clinical development for obesity ended in 2007. It is named on the WADA 2026 Prohibited List under S2.2.3, growth hormone fragments, and is prohibited at all times in sport.
Status checked 2026-09-23. Details and sources in the research note.